Nasdaq
$0.9190▲ 1.26%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $10.9MShares out 11.8M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
9- 1d agoPre-market26.10.23 22:00SCHEDULE 13G/AOwnership#●●●#●●●
CytoMed Therapeutics Ltd
mDR Ltd has filed a SCHEDULE 13G/A regarding its beneficial ownership in CytoMed Therapeutics Ltd. This filing serves to formally report changes in the shareholding position of a major beneficial owner.…more
$0.9190+1.26%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.16Pre-market26.10.16 19:05SCHEDULE 13D/AOwnership
CytoMed Therapeutics Ltd
Choo Chee Kong, a major shareholder of CytoMed Therapeutics Ltd, has filed a Schedule 13D/A to report changes in their beneficial ownership. This filing serves as an official update regarding the shareholder's equity position in the company.…more
$0.9190+1.26%vs prev closeView filingShare - 10.13Pre-market26.10.13 19:14SCHEDULE 13D/AOwnership
CytoMed Therapeutics Ltd
A SCHEDULE 13D/A filing has been submitted for CytoMed Therapeutics Ltd. Choo Chee Kong has filed as the reporting person to update their beneficial ownership status.…more
$0.9190+1.26%vs prev closeView filingShare
8 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.9After-hours26.10.10 05:30Bullish#●●●#●●●
CytoMed Therapeutics Receives Nasdaq Minimum Bid Price Deficiency Notice…more
CytoMed Therapeutics has received a notification from Nasdaq regarding its failure to maintain the minimum bid price of $1.00 per share. The company has 180 days to regain compliance with the exchange's listing rules.…more
$0.9190+1.26%vs prev closeDetected5m · 30m · 60m · Next dayPLUS